Skip to main content

Welcome to Health-NCP-Net 3.0 (HNN 3.0)

We are a network of National Contact Points (NCPs) in the area of “Health” enhancing transnational cooperation between NCPs for Cluster 1 Health in Horizon Europe to increase the support for those interested in research funding.


You are a Health-NCP and are looking for support and advice for your daily work. Here you can find the support services and activities offered by the Health-NCP-NET.

Events & Calls

You need to get an overview of all the health calls and interesting international health events. Here you will find a sorted list of EU-related calls and events from the health sector.

Funding Opportunities

You are a researcher , a research entity or company and interested in European funding opportunities for research and innovation projects. Here you can learn more about open calls in the different programs/ pillars of Horizon Europe, and other programs relevant to health research.


Information on blind evaluation in Horizon Europe

The "Blind Evaluation" is a pilot for the anonymous appraisal of short applications (stage 1) in the two-stage application process. Part B of the short application must not contain any information that give information on the identity of the applicant. Otherwise the application is considered inadmissible.
This anonymous application assessment is used in all two-stage application procedures in the 2023/2024 calls for proposals in Clusters 1 Health. Since only single-stage tenders are planned for 2023 in the health cluster, this applies to all two-stage tenders for 2024.
The EU Commission has now updated the application form for the short application and added information on "blind evaluation". The updated application form can be found on the Funding & Tenders Portal.

UK guarantee commitment extended for Horizon Europe calls

The UK is currently still in negotiations with the EU for association with Horizon Europe. Institutions from the UK can therefore currently participate in Horizon Europe applications, but will not receive any EU funding, if the UK has not been associated by the time the grant agreement is signed.
The UK government has extended the funding guarantee from national funds. The guarantee commitment covers all calls in Horizon Europe with a submission deadline before or on June 30, 2023. The Cluster Health calls have a deadline in April and are therefore covered by the funding guarantee.

Website UK Research Office

Cooperation with India for Horizon Europe Calls

Various Indian ministries, including the Ministry of Biotechnology, have provided co-financing for Indian institutions for a total of eleven call topics of the Horizon Europe program. The following three calls originate from the health cluster:

  1. HORIZON-HLTH-2023-DISEASE-03-04: Pandemic preparedness and response: Broad spectrum anti-viral therapeutics for infectious diseases with epidemic potential
  2. HORIZON-HLTH-2024-DISEASE-03-13-two-stage: Validation of fluid-derived biomarkers for the prediction and prevention of brain disorders
  3. HORIZON-HLTH2024-DISEASE-08-20: Pandemic preparedness and response: Host-pathogen interactions of infectious diseases with epidemic potential

Background: Indian institutions can participate in all Horizon Europe calls, but usually do not receive any EU funding.

More information can be found on the EURAXESS website.

Public consultation on a multi-stakeholder platform to improve clinical trials in the EU

On 3 February 2023, EMA, the Heads of Medicines Agencies (HMA) and the European Commission (EC) have launched a public consultation on the establishment of a multi-stakeholder platform to improve clinical trials in the European Union (EU). The multi-stakeholder platform is a deliverable of the joint initiative Accelerating Clinical Trials in the EU (ACT EU).

Public consultation on a multi-stakeholder platform to improve clinical trials in the EU

Scoping study on evidence to tackle high-burden under-researched medical conditions

The call topic ‘Tackling high-burden for patients, under-researched medical conditions’ (HLTH-2024-DISEASE-03-14) of the Work Programme 2023-2024 of Cluster 1 makes reference to an independent scoping study that the European Commission commissioned.
The exploratory study was aimed at helping to identify high-burden under-researched medical conditions and define the type of research and/or research priorities to better address the different needs of patients with these conditions.

The study is completed and a ‘Discussion paper’ has just been published.

Horizon Europe Association negotiations successfully concluded between the EU and New Zealand

The EU Commission and the New Zealand government have successfully concluded the association negotiations for the Horizon Europe program under Pillar II "Global Challenges and European Industrial Competitiveness". The signing of the association agreement is expected soon. This means that New Zealand institutions and scientists can then receive standard funding within the framework of calls for proposals from Pillar II of Horizon Europe, including the "Health" cluster, and also coordinate projects.

Further information

Events & Calls

Colour legend:
Call Event

Supporting initiatives and collaborations

Sign up for our newsletter

For detailed information about our privacy practices, please click here.
You can unsubscribe at any time by clicking the link in the footer of our emails.

In accordance with GDPR which harmonizes the rules on personal protection and the handling of personal information throughout Europe. In order to enforce this regulation, we would like to ask you to confirm that you want to receive information from us by email.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices here.